Alkhathami et al. demonstrated the significant upregulation of UCA1 in the serum of untreated invasive ductal carcinoma (IDC) patients compared to healthy controls, with a remarkable increase in advanced and distant organ metastatic disease patients compared to those with early-stage disease [5]. This evidence concerns the gene UCA1 and metastatic neoplasm.